Fusidic acid in vitro activity.

作者: Peter Collignon , John Turnidge

DOI: 10.1016/S0924-8579(98)00073-9

关键词: BiologyStaphylococcus aureusAntibioticsMicrobiologyMoraxellaAnaerobic bacteriaGram-negative bacteriaFusidic acidRifampicinBiochemistryAntibacterial agent

摘要: Fusidic acid is a narrow spectrum agent that acts to inhibit protein synthesis by inhibition of elongation factor G at the level ribosome. Because high binding susceptibility testing in vitro affected presence blood or serum. In addition, there modest inoculum effect vitro. A breakpoint 1 2 mg/l most widely used for defining resistance systemic treatment with fusidic acid. activity principally directed staphylococci, both Staphylococcus aureus and coagulate-negative species which are highly susceptible. It also active against Gram-positive anaerobic activity, shows Neisseria spp., Bordetella pertussis Moraxella catarrhalis. has no other aerobic Gram-negative species. Modest (MICs just above values) seen Streptococcus Enterococcus spp. as well bacteria. defined bacteriostatic. For staphylococci MBC values generally 8–32-fold MIC. Interaction studies antibiotics give varying results depending on methodology. However, interaction s-lactams indifferent, it rifampicin, while aminoglycosides macrolides appear be synergistic fluoroquinolones antagonistic. appears function neutrophils T-lymphocytes clinically achieved concentrations.

参考文章(102)
John D Turnidge, Graeme R Nimmo, Graham Francis, , Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR). The Medical Journal of Australia. ,vol. 164, pp. 68- 71 ,(1996) , 10.5694/J.1326-5377.1996.TB101350.X
Redmann U, [Effect of several water-soluble steroids on the growth of Mycoplasma gallisepticum]. Annales de l'Institut Pasteur. ,vol. 114, pp. 313- ,(1968)
Jakubicz P, Jakoniuk P, Studies on the combined action of fucidin and beta-lactam antibiotics on staphylococci. Archivum Immunologiae Et Therapiae Experimentalis. ,vol. 19, pp. 205- 209 ,(1971)
I. Stochmal, Z. Dajek, L. M. Switalski, Roman Dziarski, J. Jeljaszewicz, J. Cybulska, K. P. Schaal, W. Hryniewicz, G. Pulverer, Susceptibility of Streptococcus faecalis to 32 antimicrobial agents: comparison of patterns in Poland and Federal Republic of Germany Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie. ,vol. 235, pp. 386- 398 ,(1976)
H. Hassan, D. Felmingham, M. D. O'hare, In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria Singapore Medical Journal. ,vol. 31, pp. 56- 58 ,(1990)
Speranskaia On, Kuznetsova Sm, Fomina Ip, [Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics]. Antibiotiki. ,vol. 18, pp. 62- ,(1973)
Breyer S, Leitha T, Francesconi M, Georgopoulos A, Graninger W, Lenz K, Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin. Drugs Under Experimental and Clinical Research. ,vol. 11, pp. 23- 27 ,(1985)
Shibl Am, Ishag Ah, Durgham Sm, Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. APMIS. Supplementum. ,vol. 3, pp. 68- 70 ,(1988)
Ishag Aj, Shibl Am, Durgham Sm, In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. ,vol. 6, pp. 261- ,(1987)